The Biotech Growth Trust PLC (BIOG) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.010x

Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.52 Million ≈ $-306.25 USD) by net assets (GBX257.88 Million ≈ $31.38K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of The Biotech Growth Trust PLC to measure how much of total assets are equity-financed.

The Biotech Growth Trust PLC - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how The Biotech Growth Trust PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check The Biotech Growth Trust PLC (BIOG) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

The Biotech Growth Trust PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of The Biotech Growth Trust PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Entreprendre PA:ALENR	0.003x
Dlaboratory Sweden AB ST:DLAB	0.162x
Genetic Technologies Ltd AU:GTG	0.067x
Benjamin Hornigold Ltd AU:BHD	0.006x
DMD Digital Health Connections Group Inc NASDAQ:APTOF	0.215x
Blue Ocean Acquisition Corp NASDAQ:BOCN	-0.078x
Applied DNA Sciences Inc NASDAQ:APDN	-0.403x
Prima Alloy Steel Universal JK:PRAS	0.006x

Annual Cash Flow Conversion Efficiency for The Biotech Growth Trust PLC (2012–2025)

The table below shows the annual cash flow conversion efficiency of The Biotech Growth Trust PLC from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see how much is The Biotech Growth Trust PLC worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX221.21 Million ≈ $26.91K	GBX-5.09 Million ≈ $-618.94	-0.023x	-95.92%
2024-03-31	GBX361.31 Million ≈ $43.96K	GBX-4.24 Million ≈ $-516.01	-0.012x	+34.18%
2023-03-31	GBX330.29 Million ≈ $40.19K	GBX-5.89 Million ≈ $-716.64	-0.018x	+42.10%
2022-03-31	GBX394.21 Million ≈ $47.96K	GBX-12.14 Million ≈ $-1.48K	-0.031x	-226.48%
2021-03-31	GBX601.47 Million ≈ $73.18K	GBX-5.67 Million ≈ $-690.36	-0.009x	+8.40%
2020-03-31	GBX365.57 Million ≈ $44.48K	GBX-3.77 Million ≈ $-458.09	-0.010x	+4.27%
2019-03-31	GBX408.88 Million ≈ $49.75K	GBX-4.40 Million ≈ $-535.23	-0.011x	-9.39%
2018-03-31	GBX417.40 Million ≈ $50.79K	GBX-4.11 Million ≈ $-499.46	-0.010x	+16.56%
2017-03-31	GBX448.41 Million ≈ $54.56K	GBX-5.29 Million ≈ $-643.03	-0.012x	+24.47%
2016-03-31	GBX378.57 Million ≈ $46.06K	GBX-5.91 Million ≈ $-718.71	-0.016x	-1283.70%
2015-03-31	GBX533.30 Million ≈ $64.89K	GBX703.00K ≈ $85.53	0.001x	+100.86%
2014-03-31	GBX340.25 Million ≈ $41.40K	GBX-52.25 Million ≈ $-6.36K	-0.154x	-3352.62%
2013-03-31	GBX244.44 Million ≈ $29.74K	GBX1.15 Million ≈ $140.41	0.005x	+267.90%
2012-03-31	GBX156.13 Million ≈ $19.00K	GBX-439.00K ≈ $-53.41	-0.003x	--

About The Biotech Growth Trust PLC

LSE:BIOG UK Asset Management

Market Cap

$4.01 Million

GBX32.95 Billion GBX

Market Cap Rank

#28954 Global

#526 in UK

Share Price

GBX1588.00

Change (1 day)

-0.87%

52-Week Range

GBX816.00 - GBX1658.00

All Time High

GBX1736.00